Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gut epithelial barrier and the blood-brain barrier (BBB) are complex physiological systems that serve as the primary gatekeepers for the body's internal environment and the central nervous system, respectively. The gut barrier consists of a single layer of epithelial cells joined by tight junctions that regulate the absorption of nutrients while preventing the entry of luminal pathogens and toxins (PubMed: 23426535). The BBB is a highly specialized endothelial interface that maintains the unique microenvironment of the brain by restricting the passage of solutes and potentially harmful substances from the blood (PubMed: 16625214). These barriers are functionally linked through the gut-brain axis, where increased intestinal permeability (often termed 'leaky gut') can trigger systemic immune responses that subsequently compromise BBB integrity, contributing to neurodegenerative and autoimmune disorders (PubMed: 25880519). While not a single molecular target, specific components of these barriers, such as tight junction proteins (claudins, occludins) and efflux transporters (P-glycoprotein), are major focuses for drug delivery strategies and therapeutic intervention in inflammatory and neurological diseases.
Modulation of tight junction assembly, inhibition of ATP-binding cassette (ABC) efflux transporters, and osmotic disruption of endothelial cell-cell junctions.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut epithelial barrier and blood–brain barrier (GEB/BBB).